LXR agonists (Tanabe)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameLXR agonists (Tanabe)
Drug Alias Nameliver X receptor agonists (Mitsubishi Tanabe)liver X receptor agonists (Tanabe)LXR agonists (Mitsubishi Tanabe Pharma)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLiver X receptor agonists
TargetsLiver X receptor
Therapy Area/IndicationsLipid Metabolism DisordersDiabetes MellitusAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTanabe Seiyaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMitsubishi Tanabe Pharma CorpTanabe Seiyaku Co Ltd
Active IndicationsN/A
Inactive IndicationsLipid Metabolism DisordersDiabetes MellitusAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A